Clinical Trials In North Dakota

Discover hundreds of clinical trials in North Dakota.
Search clinical trials in North Dakota by city, condition or phase.

e.g. Respiratory Diseases

North Dakota•Healthy volunteers: No

Filter results

Results: 306

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Fargo, Bismarck, Little Rock, Anaheimshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

Phase 3

Sponsor:

SWOG Cancer Research Network

Location:

Jamestown, Fargo, Bismarck, Anchorageshow 495 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Recruiting

Phase 3

Sponsor:

Novo Nordisk A/S

Location:

Alexander City, Fairhope, Huntsville, Phoenixshow 129 more

Code:

NCT05636176

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab

Placebo

Product Surveillance Registry

Recruiting

Sponsor:

Medtronic

Location:

Birmingham, Huntsville, Anchorage, Chandlershow 126 more

Code:

NCT01524276

Conditions

Cardiac Rhythm Disorders

Urological Disorders

Neurological Disorders

Cardiovascular Disorders

Digestive Disorders

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Fairhope, Phoenix, Surprise, Tucsonshow 106 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

e.g. Respiratory Diseases

North Dakota•Healthy volunteers: No

Filter results

Results: 306

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Fargo, Bismarck, Little Rock, Anaheimshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

Phase 3

Sponsor:

SWOG Cancer Research Network

Location:

Jamestown, Fargo, Bismarck, Anchorageshow 495 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Recruiting

Phase 3

Sponsor:

Novo Nordisk A/S

Location:

Alexander City, Fairhope, Huntsville, Phoenixshow 129 more

Code:

NCT05636176

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab

Placebo

Product Surveillance Registry

Recruiting

Sponsor:

Medtronic

Location:

Birmingham, Huntsville, Anchorage, Chandlershow 126 more

Code:

NCT01524276

Conditions

Cardiac Rhythm Disorders

Urological Disorders

Neurological Disorders

Cardiovascular Disorders

Digestive Disorders

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Fairhope, Phoenix, Surprise, Tucsonshow 106 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo